NASDAQ: RLAY - Relay Therapeutics, Inc.

Lønnsomhet i seks måneder: -22.86%
Sektor: Healthcare

Kampanjeplan Relay Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Relay Therapeutics, Inc. работает как компания, специализирующаяся на прецизионных медицинских препаратах. Он занимается преобразованием процесса открытия лекарств с первоначальным акцентом на расширении терапевтических открытий малых молекул в целевой онкологии.

Flere detaljer
Его продукты-кандидаты включают RLY-1971, пероральный низкомолекулярный ингибитор протеинтирозинфосфатазы, домен гомологии области 2, фосфатазы-2 (SHP2), который находится в фазе 1 исследований повышения дозы у пациентов с запущенными или метастатическими солидными опухолями; RLY-4008, пероральный низкомолекулярный селективный ингибитор рецептора 2 фактора роста фибробластов (FGFR2) для пациентов с развитыми солидными опухолями, имеющими онкогенные изменения FGFR2; и RLY-PI3K1047, ведущее соединение, которое нацелено на ассоциированные с раком мутантные варианты фосфоинозитид-3-киназы альфа. Компания была основана в 2015 году, ее штаб-квартира находится в Кембридже, штат Массачусетс.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

P/BV 2.37
EV/EBITDA 0.2109
EBITDA -0.0812
Цена ао 6.42
P/S 21.87
Сайт http://www.relaytx.com
Число акций ао 0.12258 млрд
P/E 17.31
Выручка 0.0827
Див.доход ао 0
ISIN US75943R1023
Валюта usd
IPO date 2020-07-16
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Prisendring per dag: 0% (4.86)
Prisendring per uke: +1.25% (4.8)
Prisendring per måned: -19.27% (6.02)
Prisendring over 3 måneder: -28.84% (6.83)
Prisendring over seks måneder: -22.86% (6.3)
Prisendring per år: -40.44% (8.16)
Prisendring over 3 år: -83.4% (29.28)
Prisendring siden begynnelsen av året: -57.37% (11.4)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 55.08 1
P/BV 1.87 8
P/E 17.31 7
EV/EBITDA -3.46 0
Total: 4.88

Effektivitet

Navn Betydning Karakter
ROA, % -40.52 0
ROE, % -45.47 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.1405 10
Total: 8.2

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -69.11 0
Lønnsomhet Ebitda, % 368.69 10
Lønnsomhet EPS, % -85.54 0
Total: 6
Flere detaljer

Transaksjonsdato Avsløringsdato Insider Type Pris Volum Mengde Del opp til, % Del etterpå, % Dokument
28.10.2024 30.10.2024 Adams Brian
Chief Legal Officer		 Salg 6.06 9 890 1632 0 0 link
28.10.2024 28.10.2024 THOMAS J CATINAZZO
Officer		 Kjøpe 6.06 30 936 5105 0 0 link
27.09.2024 01.10.2024 Adams Brian
Chief Legal Officer		 Salg 7.51 2 215 295 0 0 link
27.09.2024 01.10.2024 Bergstrom Donald A
President, R&D		 Salg 7.51 4 866 648 0 0 link
27.09.2024 01.10.2024 Catinazzo Thomas
Chief Financial Officer		 Salg 7.46 48 169 6457 0 -0.01 link
27.09.2024 01.10.2024 Rahmer Peter
See remarks		 Salg 7.51 1 840 245 0 0 link
10.06.2024 12.06.2024 Rubin Jami
Director		 Kjøpe 5.04 212 900 42242 0 0.04 link
29.04.2024 29.04.2024 Bergstrom Donald A
President, R&D		 Salg 6.38 17 137 2686 0 0 link
29.04.2024 29.04.2024 Catinazzo Thomas
Chief Financial Officer		 Salg 6.38 10 814 1695 0 0 link
29.04.2024 29.04.2024 Adams Brian
Chief Legal Officer		 Salg 6.38 10 355 1623 0 0 link
29.04.2024 29.04.2024 Rahmer Peter
See remarks		 Salg 6.38 8 581 1345 0 0 link
27.03.2024 29.03.2024 Adams Brian
Chief Legal Officer		 Salg 7.7 2 680 348 0 0 link
27.03.2024 29.03.2024 Rahmer Peter
See remarks		 Salg 7.7 2 295 298 0 0 link
27.03.2024 29.03.2024 Bergstrom Donald A
President, R&D		 Salg 7.7 5 891 765 0 0 link
27.03.2024 29.03.2024 Catinazzo Thomas
Chief Financial Officer		 Salg 7.7 2 680 348 0 0 link
27.06.2023 28.06.2023 Adams Brian
Chief Legal Officer		 Salg 12.12 3 563 294 0 0 link
27.06.2023 28.06.2023 Bergstrom Donald A
President, R&D		 Salg 12.12 7 842 647 0 0 link
27.12.2022 28.12.2022 Adams Brian
Chief Legal Officer		 Salg 14.49 4 275 295 0 0 link
27.12.2022 28.12.2022 Bergstrom Donald A
President, R&D		 Salg 14.49 14 200 980 0 0 link
27.12.2022 28.12.2022 Catinazzo Thomas
Chief Financial Officer		 Salg 14.49 6 448 445 0 0 link
13.10.2022 13.10.2022 Patel Sanjiv
President and CEO		 Salg 20.58 288 120 14000 0 -0.01 link
11.10.2022 13.10.2022 Patel Sanjiv
President and CEO		 Salg 21.36 299 040 14000 0 -0.01 link
27.09.2022 29.09.2022 Adams Brian
Chief Legal Officer		 Salg 22.73 6 683 294 0 0 link
27.09.2022 29.09.2022 Bergstrom Donald A
President, R&D		 Salg 22.73 22 184 976 0 0 link
08.09.2022 08.09.2022 Bergstrom Donald A
President, R&D		 Salg 30 750 000 25000 0 -0.02 link
08.09.2022 08.09.2022 Bergstrom Donald A
President, R&D		 Kjøpe 4.12 103 000 25000 0 0.02 link
08.09.2022 08.09.2022 Catinazzo Thomas
Chief Financial Officer		 Salg 30 787 710 26257 0 -0.02 link
01.09.2022 01.09.2022 Bergstrom Donald A
President, R&D		 Salg 23.07 186 867 8100 0 -0.01 link
01.09.2022 01.09.2022 Bergstrom Donald A
President, R&D		 Kjøpe 4.12 33 372 8100 0 0.01 link
24.08.2022 25.08.2022 Bergstrom Donald A
President, R&D		 Salg 25 375 000 15000 0 -0.01 link
24.08.2022 25.08.2022 Bergstrom Donald A
President, R&D		 Kjøpe 4.12 61 800 15000 0 0.01 link
24.03.2022 28.03.2022 Bergstrom Donald A
President, R&D		 Salg 30 300 000 10000 0 -0.01 link
24.03.2022 28.03.2022 Bergstrom Donald A
President, R&D		 Kjøpe 4.12 41 200 10000 0 0.01 link
24.03.2022 28.03.2022 Catinazzo Thomas
Chief Financial Officer		 Salg 30 398 580 13286 0 -0.01 link
24.03.2022 28.03.2022 Catinazzo Thomas
Chief Financial Officer		 Kjøpe 4.12 54 738 13286 0 0.01 link

Institusjoner Volum Dele, %
SB INVESTMENT ADVISERS (UK) LTD 27904963 21.27
Vanguard Group Inc 10650387 8.12
Blackrock Inc. 9573423 7.3
Price (T.Rowe) Associates Inc 8581167 6.54
Casdin Capital, LLC 7387943 5.63
JP Morgan Chase & Company 6065595 4.62
Bellevue Group AG 5936082 4.53
State Street Corporation 4903578 3.74
BVF Inc. 3970045 3.03
ArrowMark Colorado Holdings LLC 3914246 2.98

ETF Dele, % Lønnsomhet for året, % Utbytte, %
Avantis U.S Small Cap Equity ETF 0.11461 27.774101036841 1.68271
Avantis Responsible U.S. Equity ETF 0.00001 26.778312788906 1.45257
Avantis U.S. Equity ETF 0.00174 32.224830464267 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 0.75923 63.040315712071 0.33
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.0475 24.74842126706 1.59225
ProShares Ultra Nasdaq Biotechnology 0.06686 51.697637072723 0.85651
Range Cancer Therapeutics ETF 1.26796 47.24446537918 0.11955
Dimensional U.S. Core Equity 2 ETF 0.00299 30.755198832543 1.47098
Dimensional U.S. Targeted Value ETF 0.01459 26.007247921552 1.93487
Dimensional US Core Equity Market ETF 0.00222 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00101 31.530984204131 1.3557
Vanguard ESG U.S. Stock ETF 0 32.395678092399 1.26927
Fidelity MSCI Health Care Index ETF 0.01424 13.390080209527 1.46057
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.01964 31.359936575053 1.41955
ProShares Hedge Replication ETF 0.00461 5.9237999659878 1.47892
Humankind US Stock ETF 0.00452 18.809430395549 1.99919
Invesco Nasdaq Biotechnology ETF 0.1004 28.578975171685 0.8565
iShares Morningstar Small-Cap ETF 0.01505 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.02976 33.628071953382 0.72598
iShares Russell 3000 ETF 0.00101 32.57283798366 1.43482
iShares Morningstar Small-Cap ETF 0.01505 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.02976 680.05582339508 0.72598
Direxion Daily S&P Biotech Bull 3x Shares 0.12386 4067.9190751445 0.25924
TrueShares Technology, AI & Deep Learning ETF 1.02465 24.669836238774 0.0924
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02179 35.452103849597 1.75869
Schwab U.S. Small-Cap ETF 0.02126 34.281650071124 1.51433
Schwab U.S. Broad Market ETF 0.00108 32.5 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.00525 23.600605143722 2.19607
ProShares UltraPro Russell2000 0.01612 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 ETF 0.03 35.648084105685 1.48801
Principal Healthcare Innovators ETF 0.09706 618.4964157054 0.8416
Future Tech ETF 0.09706 426.33969118983 0.8416



Veileder Stillingstittel Betaling Fødselsår
Mr. Brian R. Adams J.D. Chief Legal Officer & Secretary 598.53k 1974 (50 år)
Mr. Thomas Catinazzo Chief Financial Officer 599.83k 1977 (47 år)
Mr. Peter Rahmer Chief Corporate Development Officer 570.52k
Mr. Alexis A. Borisy A.M. Co-Founder & Independent Chairman 85k 1972 (52 år)
Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS CEO, President & Director 1.03M 1974 (50 år)
Dr. Mark Murcko Ph.D. Co-Founder & Director 50k 1960 (64 år)
Dr. Donald A. Bergstrom M.D., Ph.D. President of Research & Development 711.25k 1972 (52 år)
Ms. Dorothee Kern Ph.D. Founder
Dr. David Elliot Shaw Ph.D. Founder 1951 (73 år)
Mr. Matthew P. Jacobson Ph.D. Founder

Adresse: United States, Cambridge, MA , 399 Binney Street - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.relaytx.com